IBDEI0K1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8833,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,8833,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,8834,0)
 ;;=E10.40^^69^602^5
 ;;^UTILITY(U,$J,358.3,8834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8834,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,8834,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,8834,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,8835,0)
 ;;=E10.22^^69^602^2
 ;;^UTILITY(U,$J,358.3,8835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8835,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,8835,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,8835,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,8836,0)
 ;;=E10.9^^69^602^7
 ;;^UTILITY(U,$J,358.3,8836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8836,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,8836,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,8836,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,8837,0)
 ;;=E11.22^^69^602^8
 ;;^UTILITY(U,$J,358.3,8837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8837,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,8837,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,8837,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,8838,0)
 ;;=E11.9^^69^602^12
 ;;^UTILITY(U,$J,358.3,8838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8838,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,8838,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,8838,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,8839,0)
 ;;=E13.22^^69^602^1
 ;;^UTILITY(U,$J,358.3,8839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8839,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,8839,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,8839,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,8840,0)
 ;;=E83.30^^69^603^26
 ;;^UTILITY(U,$J,358.3,8840,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8840,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,8840,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,8840,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,8841,0)
 ;;=E83.31^^69^603^9
 ;;^UTILITY(U,$J,358.3,8841,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8841,1,3,0)
 ;;=3^Familial Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,8841,1,4,0)
 ;;=4^E83.31
 ;;^UTILITY(U,$J,358.3,8841,2)
 ;;=^5002998
 ;;^UTILITY(U,$J,358.3,8842,0)
 ;;=E83.51^^69^603^19
 ;;^UTILITY(U,$J,358.3,8842,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8842,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,8842,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,8842,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,8843,0)
 ;;=E83.52^^69^603^13
 ;;^UTILITY(U,$J,358.3,8843,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8843,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,8843,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,8843,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,8844,0)
 ;;=E87.0^^69^603^16
 ;;^UTILITY(U,$J,358.3,8844,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8844,1,3,0)
 ;;=3^Hyperosmolality and Hypernatremia
 ;;^UTILITY(U,$J,358.3,8844,1,4,0)
 ;;=4^E87.0
 ;;^UTILITY(U,$J,358.3,8844,2)
 ;;=^5003018
 ;;^UTILITY(U,$J,358.3,8845,0)
 ;;=E87.1^^69^603^18
 ;;^UTILITY(U,$J,358.3,8845,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8845,1,3,0)
 ;;=3^Hypo-osmolality and Hyponatremia
 ;;^UTILITY(U,$J,358.3,8845,1,4,0)
 ;;=4^E87.1
 ;;^UTILITY(U,$J,358.3,8845,2)
 ;;=^5003019
 ;;^UTILITY(U,$J,358.3,8846,0)
 ;;=E87.2^^69^603^1
 ;;^UTILITY(U,$J,358.3,8846,1,0)
 ;;=^358.31IA^4^2
